CSIMarket
 

Capsovision Inc   (NASDAQ: CV)

Capsovision Inc 's

Competitiveness




 

CV Sales vs. its Competitors Q1 2026







Revenue Growth Comparisons




Net Income Comparison




<<  CV Stock Performance Comparisons


Capsovision Inc 's Comment on Competition and Industry Peers


The capsule endoscopy market includes products featuring end-view systems that provide limited views of the small bowel and use wired data recorders worn on the body, which require upfront capital expenses and complicate clinical workflows. The CapsoCam Plus system offers a full 360° panoramic video using four high-resolution cameras, wire-free data collection without capital expenses, and telemedicine-enabled remote data access. A large retrospective study demonstrated CapsoCam's advantages in lesion detection, visualization, exam completion rates, and data retention. In colon capsule endoscopy, two competitive products exist, with Medtronic's PillCam COLON 2 being the only product available in the U.S. The CapsoCam Colon, pending FDA clearance, is designed to utilize proprietary AI for automated polyp detection to enhance diagnostic yield and consistency. Competitors identified include Medtronic.



*Market share is calculated based on total revenue.





Publicly Traded Peers of Capsovision Inc



Sources: Capsovision Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Capsovision Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.